Christine A Iacobuzio-Donahue

Title: Christine A Iacobuzio-Donahue: Innovator in Cancer Research

Introduction

Christine A Iacobuzio-Donahue is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of cancer research, particularly in understanding epigenetic reprogramming and its implications for cancer treatment. With a total of 2 patents to her name, her work is paving the way for advancements in cancer diagnostics and therapeutics.

Latest Patents

Her latest patents include "Identification of epigenomic reprogramming in cancer and uses thereof" and "Methods of screening for cell proliferation or neoplastic disorders." The first patent relates to a method of identifying epigenetic reprogramming by detecting large organized heterochromatin lysine (K)-9 modified domains (LOCKs) and large DNA hypomethylated blocks in samples from cancer patients, such as those with pancreatic ductal adenocarcinoma (PDAC). The second patent focuses on methods and compositions for identifying subjects with, or predisposed to, neoplastic disorders, applicable to various tissue samples.

Career Highlights

Christine has worked with esteemed institutions such as The Johns Hopkins University and Memorial Sloan Kettering Cancer Center. Her research has significantly impacted the understanding of cancer biology and has the potential to improve patient outcomes through innovative diagnostic methods.

Collaborations

Some of her notable collaborators include Andrew P Feinberg and Oliver McDonald. Their collective expertise has contributed to the advancement of cancer research and the development of new methodologies in the field.

Conclusion

Christine A Iacobuzio-Donahue is a trailblazer in cancer research, with her innovative patents and collaborations driving forward the understanding of cancer and its treatment. Her work exemplifies the critical role of inventors in advancing medical science and improving patient care.